Tau positron emission tomography,cerebrospinal fluid and plasma biomarkers of neurodegeneration,and neurocognitive testing: an exploratory study of participants with myotonic dystrophy type 1
1.Clinique Interdisciplinaire de Mémoire, CHU de Québec, Québec, QC, Canada ;2.Biogen Inc, Cambridge, MA, USA ;3.Université de Lille, Inserm UMRS1172, CHU Lille, Lille, France ;4.Alzheimer & Tauopathies, LabEx DISTALZ, Lille, France ;
Abstract:
Journal of Neurology - To investigate Tau pathology using multimodal biomarkers of neurodegeneration and neurocognition in participants with myotonic dystrophy type 1 (DM1). We recruited twelve...